Top Stories
Supporters of U.S. President-elect Donald Trump gather outside Capital One Arena, for…
BioVaxys Technology Corp. is developing its patented DPX™ platform to address the challenges of lipid nanoparticles (LNPs) in mRNA vaccine delivery. Learn how DPX improves stability, immune responses, and manufacturing economics as the mRNA vaccine market projects $48 billion growth by 2030.
(Reuters) -The first three Israeli hostages were released from Gaza on…
By Avi (JO:) Ohayon SDEROT, Israel (Reuters) – Hundreds of Israelis…
New York, New York–(Newsfile Corp. – January 19, 2025) – WHY:…
New York, New York–(Newsfile Corp. – January 19, 2025) – WHY:…
Investments
The path to financial independence is a journey, not a destination. There…
Economy Insights
National News
Given the large stake in the stock by institutions, First Western Financial’s stock price might be vulnerable to their trading decisions The top 14 shareholders own 52%…
Image source: Getty Images Some passive income ideas are simpler than others – a lot simpler. For example, my own approach is buying blue-chip shares in proven…
New York, New York–(Newsfile Corp. – January 18, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Xerox (NASDAQ:)…
New York, New York–(Newsfile Corp. – January 18, 2025) – Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Regeneron (NASDAQ:) To Contact Him Directly To Discuss Their…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Rentokil To Contact Him Directly To Discuss Their Options…